A predictive model of recurrent lower extremity cellulitis in a population-based cohort

Archives of Internal Medicine

Volumn 167, Issue 7, 2007, Pages 709-715

  McNamara, David R ^a,b   Tleyjeh, Imad M ^a   Berbari, Elie F ^a   Lahr, Brian D ^a   Martinez, Jeffrey ^a   Mirzoyev, Sultan A ^a   Baddour, Larry M ^a  

^a MAYO CLINIC   (United States)

^b Meritcare Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; CELLULITIS; COHORT ANALYSIS; CONTROLLED STUDY; DERMATITIS; FEMALE; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TIBIA;

AGED; CELLULITIS; COHORT STUDIES; FEMALE; FORECASTING; HUMANS; LEG; MALE; MIDDLE AGED; MODELS, STATISTICAL; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 34247092386     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.7.709     Document Type: Review

References (16)

1. Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999;318:1591-1594.
2. Roujeau JC, Sigurgeirsson B, Korting HC, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a casecontrol study. Dermatology. 2004;209:301-307.
3. Bjornsdottir S, Gottfredsson M, Thorisdottir AS, et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005;41:1416-1422.
4. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266-274.
5. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
6. Hospital Adaptation of the International Classification of Diseases, Adapted. Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1968.
7. Calandra GB, Norden C, Nelson JD, Mader JT; Infectious Diseases Society of America; US Food and Drug Administration. Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure. Clin Infect Dis. 1992;15(suppl 1):S148-S154.
8. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373-1406.
9. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1983;37:36-48.
10. Fowler VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066-2072.
11. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
12. Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004;350:904-912.
13. Hook EW III, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295-297.
14. Ekelund K, Skinhoj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect. 2005;11:569-576.
15. Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med. 1985;79:155-159.
16. Mokni M, Dupuy A, Denguezli M, et al. Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology. 2006;212:108-112.